Delivery Order HHSN261201600012I-HHSN26100002

<p>This is a $632,469.60 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Biopartners, Inc. The contract supports the Tissue Source Site for Tumor Analysis program and has a final completion date of September 4, 2021. There was no set-aside designation for this award. The contract does not mention any major subcontractors.</p>

The National Cancer Institute (NCI) awarded a $71,250.00 Firm Fixed Price Delivery Order to the Miedzynarodowy Instytut Onkologii Molekularnej, a foundation located in Poland, for medical images of biospecimens under the Tissue Source Site for Tumor Analysis contract vehicle. The work is part of the NCI's CPTAC (Clinical Proteomic Tumor Analysis Consortium) program, which focuses on generating and analyzing comprehensive clinical proteomic data for cancer research. This contract does not have...

This is a Firm Fixed Price Delivery Order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Indivumed, Inc., a For Profit Organization. The contract is for the recovery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The potential value of this contract is $38,000.00. It is not associated with a set-aside designation. The contract is issued under the NCI Cancer Genome...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The total ceiling value of the contract is $42,000.00. This contract is part of the NCI's Cancer Genome Atlas Program Tissue Purchase master IDIQ contract. The contract...

This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Biomatrix LLC, a woman-owned and Asian-Pacific American-owned limited liability company, for $348,699.80. The award is for Biomatrix to serve as a Tissue Source Site (TSS) for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The contract has a period of performance through April 29, 2019 and does not have a set-aside designation. The CPTAC program is focused on the...

This is a firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Digital Artefacts LLC, a minority-owned, small disadvantaged business. The contract is for the development of a &quot;CANCER PATIENT COGNITIVE ASSESSMENT PLATFORM&quot; under TOPIC 343, with a ceiling value of $216,431.00 and a completion date of September 18, 2017. The contract does not have a set-aside designation. As the NCI is the funding agency, this contract supports the...

This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Cureline Inc., a woman-owned small business. The contract is for the procurement of breast ductal, colon, head and neck, lung adenocarcinoma, lung squamous, kidney renal, stomach, uterine corpus, and melanoma tissue samples under the NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The contract has a ceiling value of $212,610.63 and a completion date of January 24,...

This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Melanoma Institute Australia, a foreign-owned non-profit organization. The contract is for $192,500.00 and is related to the NCI Cancer Genome Atlas Program, which involves the collection of tissue samples and data from various types of cancer. There is no set-aside designation for this contract. The contract is a Firm Fixed Price type and has an ultimate completion date of September 30, 2014....

This is a $884,040.57 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the acquisition of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract was awarded to Indivumed, Inc., a for-profit organization, and is not set aside for any special designation. The contract is a delivery order under the NCI Cancer...

This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Ilsbio LLC, a for-profit limited liability company. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. This award is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract and is funded under the American Recovery and Reinvestment Act (ARRA). The contract has a...